StockData
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO) stock

BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$76.80−0.56 (-0.72%)

Close on Nov 17, 2026Market cap $14.96BP/E –Yield –

BridgeBio Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BridgeBio Pharma's market cap was $15.53B on Nov 11, 2026, against $13.87B a year earlier. Over the last 5 years it ranged from $1.01B to $15.67B, with a median of $5.24B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$15.53B+5.4%
2025Dec 31, 2025$14.73B+184.1%
2024Dec 31, 2024$5.19B-26.2%
2023Dec 29, 2023$7.03B+517.6%
2022Dec 30, 2022$1.14B-53.6%
2021Dec 31, 2021$2.45B-71.8%
2020Dec 31, 2020$8.71B+111.8%
2019Dec 31, 2019$4.11B–

More BridgeBio Pharma figures

See a number that looks wrong?